Dr. Omid S. Shaye, MD

Dr. Shaye practices at Valley Surgical Center LLC in West Hills, California.

Dr. Shaye's NPI, 1861611931, was assigned on April 25, 2007. Dr. Shaye graduated from Keck School of Medicine of USC in 2001. Dr. Shaye holds California license A81628.

Dr. Shaye's primary practice is Valley Surgical Center LLC, at 7320 N Woodlake Ave, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 610-3966.

Dr. Shaye's primary practice is Valley Surgical Center LLC in West Hills, California. Dr. Shaye is also affiliated with UCLA West Valley Medical Center. The medical group on file is Wellness Oncology & Hematology. Dmand AI also links Dr. Shaye to 3 more hospitals, 1 group practice or clinic, 1 home health agency and 1 hospice, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shaye practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shaye's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shaye is board certified in medical oncology by the American Board of Internal Medicine. Dr. Shaye is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Shaye treats.

CMS data shows 68,247 Medicare services from Dr. Shaye across 59 procedure codes in 2024, for 756 Medicare patients. Medicare paid $2,096,940 for them.

CMS counts 756 Medicare patients who saw Dr. Shaye in 2024. The largest group is 75 to 84, with 329 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shaye's median patient age at 72, with 64% women.

In 2024, Dr. Shaye wrote 2,126 Medicare Part D claims for 324 patients. 62% of them were for generic drugs. CMS names the drug for 1,508 of them, across 58 drugs with 11 or more claims each, at $5,869,618 in total drug cost. In 2023, CMS named 1,459 claims across 60 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Shaye for performance year 2024, reported as part of a group. Dr. Shaye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shaye as offering telehealth.

Dmand AI links 2 papers to Dr. Shaye in 2011.

Dmand AI links Dr. Shaye to 1 clinical trial. Conditions studied include Anemia, Iron-Deficiency and Anemia, Hypochromic. Open Payments lists research payments to Dr. Shaye that name 1 trial.

CMS Open Payments shows 357 general payments to Dr. Shaye from 82 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Bristol-Myers Squibb Company paid the most, $539. It also lists 2 research payments totaling $5,625 from 2017 to 2018, naming 1 clinical trial.

Dr. Shaye graduated from Keck School of Medicine of USC in 2001.

Dr. Shaye is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.